On the upside
Swiss regulators approved Cerus' (Nasdaq: CERS) Intercept Blood System for deactivating viruses, bacteria and parasites in blood to be used for transfusions.
La-Z-Boy (NYSE: LZB) reversed year ago losses to post a profit for the first quarter due to a decrease in charges.
Candela (Nasdaq: CLZR) swung to a fourth quarter profit even as revenue fell.
On the downside
Longtop Financial Technologies (NYSE: LFT) reported higher first quarter earnings but the results fell short of estimates.
Yingli Green Energy (NYSE: YGE) blamed one time charges for swinging to a second quarter loss.
Third quarter earnings for Eaton Vance (NYSE: EV) fell as revenue dropped.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 4 points to 560.
